About
Sutro Biopharma (NASDAQ:STRO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 19 2026
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
Mar 23 2026
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Feb 23 2026
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
Feb 10 2026
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
Jan 7 2026
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Financials
Revenue
$102.48 M
Market Cap
$443.34 M
EPS
-22.30
Translate